Dogs may be bred as long as they are mostly fertile, and it is still important to preserve this species' capacity for reproduction [1]. Before a male's reproductive life begins, the quality of its semen can be used to forecast the male's probable fertility [2]. Breeders and practitioners currently focus a great deal of attention on the reproductive failure of the canine species, and they search for targeted therapies to address this issue. Several cases of presumed sub- and infertility are caused by male factors, particularly when the patient presents with an altered semen analysis [3, 4]. The infertility of male dogs is still a subject of little understanding. Poor semen quality is one of the many issues that might cause it [5–8]. Reduced spermatozoa production by the testes during the course of reproductive life is a notable clinical disorder known as oligozoospermia. Although its pathogenesis is yet unknown, oligozoospermia is thought to be one of the most common clinical reasons for male infertility in humans [9, 10].To date, no single medication has been found to be effective in treating the condition. Much study on using natural sources to treat oligozoospermia has been conducted in the past 10 years [11]. According to recent research, 15–20% of male dogs raised for breeding have subfertility issues [12]. Seminal analysis is used to diagnose the main issues, which are connected to low-quality semen, much like in humans. According to Rijsselaere et al. [13] and Domosławska et al.[5], the majority of assessed motility parameters, sperm concentration, and the percentage of spermatozoa with normal morphology are all considerably lower in infertile dogs than in fertile dogs. Sperm cell concentration is typically assessed for evaluating semen in dogs, although it is not a very useful indication because it is inversely related to ejaculate volume [2]. In recent years, many researchers have reported the impact of extracellular vesicles (EVs) on animal reproduction and fertility [14, 15]. Extracellular vesicles (EVs) are membrane-bound nanovesicles released by cells that are capable of carrying cargo between cells as a means of intercellular communication. This cargo includes proteins, DNA, and RNA. Based on their biogenesis or release mechanisms, many EV forms, including microvesicles (MVs), exosomes, oncosomes, and apoptotic bodies, have been described. Microvesicles originate from the plasma membrane directly, possessing cytoplasmic cargo and ranging in size from 100 nm to 1 µm [16]. According to El Andaloussi et al. [17] and Cocucci and Meldolesi [18], multivesicular bodies produce smaller vesicles, known as exosomes, with diameters ranging from 40 to 120 nm, when they fuse with the plasma membrane. Exosomes act as both endocrine and paracrine mediators in interactions with neighboring cells, which is crucial for cell-to-cell communication [19]. However, dying cells produce vesicular apoptotic bodies (50 nm–2 µm), which can vary in composition between biofluids and, under some circumstances, be more common than exosomes or MVs [17, 20]. In addition, membrane protrusions can give rise to large EVs called oncosomes (1–10 µm), which, unlike their non-transformed counterparts, are preferentially generated by malignant cells [21]. EVs can be found in a variety of bodily fluids, including breast milk, urine, saliva, and blood [22]. The EVs circulate freely in all bodily fluids until they attach to target cells that are close to or far from their site of origin. Once the target cells get their cargo, they may change the way they operate [23]. Thus, EVs are crucial for cell-to-cell communication and have a function in a variety of pathologies, such as immunological responses, cancer, neurological diseases, and physiological reproductive processes such as placenta development and embryo implantation [24–26]. Although seminal plasma was among the first organic fluid EVs to be isolated and described, it continues to be one of the least studied [27]. Compared to blood or cerebrospinal fluid, the concentration of EVs in seminal plasma is comparatively greater [28]. Male accessory glands, specifically the vesicular and prostate glands, as well as functional cells of the testis, epididymis, and vas deferens, release seminal EVs (sEVs) [29]. Seminal EVs participate in a variety of reproductive processes by binding to and exchanging active molecules with mature sperm and endometrial epithelial cells [26, 29]. Therefore, sperm motility, capacitation, and acrosome reaction, all functional sperm characteristics necessary for fertilization, would be regulated by sEVs. Additionally, normozoospermic and non-normozoospermic males have different cargo loads on sEVs [30]. By regulating the uterine immune response, seminal EVs would also aid in the safe passage of spermatozoa via the female genital canal [31].Extracellular vesicles (EVs) originating from stem cells have the capacity to trigger angiogenesis in endothelial cells [32], suppress cell death and promote cell proliferation [33], transmit immunomodulatory signals [34], and reprogram cells necessary for tissue regeneration [35]. The drawbacks of fresh exosomal solutions include the need to isolate and re-inject the solution into the same individual, their short shelf life, and the lengthy preparation period. Because of this, using preserved EVs was required in order to make them suitable for clinical application. Freeze drying, also known as lyophilization, is a technique used to preserve perishable items by dehydrating samples to delay degradation. Water is necessary for the development of microbes and the action of enzymes. Lyophilization is the best method for preserving thermosensitive substances like EVs, vaccines, viruses, proteins, peptides, and colloidal carriers because it is a two-step preservation process that involves freezing water and then removing it under pressure (4.579 mm of Hg) and at a temperature below 0.0099°C [19]. The research states that low sperm concentration and/or function are the main reasons impeding breeding programs. Consequently, several studies investigated different protocols to enhance semen quality in veterinary and human medicine using a specific daily intake of micronutrients as supplements [36–39]. For dogs, not much information is available [40, 41]. Furthermore, to the best of the authors' knowledge, there is no information available for dogs about the impact on semen quality of a single intra-testicular injection of lyophilized xenogenous mesenchymal stem cell-derived extracellular vesicles (human MSCs-derived EVs) or allogeneic mesenchymal stem cell-derived extracellular vesicles (canine MSCs-derived EVs). Therefore, in oligozoospermic dogs, the current study examined this influence on semen quality and testicular blood flow.